AstraZeneca has revealed thrilling plans for a full US stock market listing, assuring investors that its UK headquarters will stay firmly rooted. This bold strategy aims to boost access for US investors while proudly preserving its rich British heritage
Brazil’s groundbreaking update to drug pricing regulations is shaking up the pharmaceutical landscape! Companies are now required to present stronger evidence showcasing their products’ effectiveness and cost-efficiency. This pivotal change could transform market dynamics and enhance access to vital medications throughout the country.
